Taiflex Scientific Co., Ltd. (TPE:8039)
Taiwan · Delayed Price · Currency is TWD 143.50
-4.50 (-3.04%)
Jun 25, 2026, 1:30 PM CST
Taiflex Scientific Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,798 | 10,609 | 9,938 | 8,151 | 8,722 | 9,405 | |
Revenue Growth (YoY) | 5.95% | 6.75% | 21.93% | -6.55% | -7.26% | 7.29% |
Cost of Revenue | 8,642 | 8,568 | 7,800 | 6,359 | 6,643 | 7,206 |
Gross Profit | 2,156 | 2,041 | 2,138 | 1,792 | 2,079 | 2,199 |
Selling, General & Admin | 1,092 | 1,063 | 1,052 | 934.43 | 1,024 | 931 |
Research & Development | 498.1 | 458.98 | 394.32 | 366.52 | 400.59 | 323.22 |
Operating Expenses | 1,600 | 1,549 | 1,475 | 1,304 | 1,431 | 1,250 |
Operating Income | 555.46 | 492.31 | 662.72 | 487.6 | 648.08 | 948.81 |
Interest Expense | -22.99 | -22.58 | -31.35 | -32.46 | -35.21 | -20.8 |
Interest & Investment Income | 32.56 | 34.51 | 36.73 | 27.57 | 15.28 | 5.37 |
Earnings From Equity Investments | -2.23 | -3.54 | -2.11 | -11.16 | -1.6 | -7.97 |
Currency Exchange Gain (Loss) | 55.1 | 18.43 | 131.54 | -40.02 | 255.1 | -1.05 |
Other Non Operating Income (Expenses) | 61.19 | 44.22 | -9.99 | 50.3 | -44.6 | 18.65 |
EBT Excluding Unusual Items | 679.09 | 563.35 | 787.55 | 481.82 | 837.04 | 943.02 |
Gain (Loss) on Sale of Investments | 49.62 | 49.62 | -26.88 | 0.81 | 39.85 | 1.61 |
Gain (Loss) on Sale of Assets | 0.36 | 0.76 | -33.45 | -0.31 | 0.43 | -6.69 |
Asset Writedown | 0.45 | 1.02 | -26.23 | - | - | 2.88 |
Pretax Income | 729.52 | 614.75 | 701 | 482.32 | 877.31 | 940.81 |
Income Tax Expense | 114.22 | 89.73 | 168.51 | 121.6 | 185.6 | 195.95 |
Earnings From Continuing Operations | 615.3 | 525.03 | 532.49 | 360.72 | 691.71 | 744.86 |
Minority Interest in Earnings | 8.66 | 10.09 | 60.29 | 62.25 | 8.77 | -10.21 |
Net Income | 623.95 | 535.12 | 592.78 | 422.97 | 700.48 | 734.65 |
Net Income to Common | 623.95 | 535.12 | 592.78 | 422.97 | 700.48 | 734.65 |
Net Income Growth | 14.91% | -9.73% | 40.14% | -39.62% | -4.65% | -4.94% |
Shares Outstanding (Basic) | 260 | 259 | 235 | 219 | 219 | 219 |
Shares Outstanding (Diluted) | 264 | 264 | 259 | 263 | 261 | 258 |
Shares Change (YoY) | 1.59% | 1.68% | -1.43% | 0.83% | 0.92% | 17.36% |
EPS (Basic) | 2.40 | 2.07 | 2.53 | 1.93 | 3.20 | 3.36 |
EPS (Diluted) | 2.37 | 2.04 | 2.32 | 1.66 | 2.74 | 2.85 |
EPS Growth | 12.14% | -12.29% | 39.47% | -39.30% | -3.74% | -18.84% |
Free Cash Flow | 652.41 | 112.67 | 727.6 | 256.7 | 164.64 | -301.13 |
Free Cash Flow Per Share | 2.48 | 0.43 | 2.81 | 0.98 | 0.63 | -1.17 |
Dividend Per Share | 2.000 | 2.000 | 2.500 | 0.879 | 2.390 | 2.390 |
Dividend Growth | -20.00% | -20.00% | 184.35% | -63.21% | - | - |
Gross Margin | 19.97% | 19.24% | 21.51% | 21.98% | 23.84% | 23.38% |
Operating Margin | 5.14% | 4.64% | 6.67% | 5.98% | 7.43% | 10.09% |
Profit Margin | 5.78% | 5.04% | 5.96% | 5.19% | 8.03% | 7.81% |
Free Cash Flow Margin | 6.04% | 1.06% | 7.32% | 3.15% | 1.89% | -3.20% |
EBITDA | 1,064 | 993.95 | 1,142 | 896.01 | 1,035 | 1,302 |
EBITDA Margin | 9.85% | 9.37% | 11.49% | 10.99% | 11.87% | 13.84% |
D&A For EBITDA | 508.36 | 501.65 | 478.96 | 408.41 | 386.8 | 353.15 |
EBIT | 555.46 | 492.31 | 662.72 | 487.6 | 648.08 | 948.81 |
EBIT Margin | 5.14% | 4.64% | 6.67% | 5.98% | 7.43% | 10.09% |
Effective Tax Rate | 15.66% | 14.60% | 24.04% | 25.21% | 21.16% | 20.83% |